AlphaFold predicted structure
IDH3G · P51553

Mean pLDDT
88.6/ 100
Confident
393 residues
Confidence breakdown
- Very high(≥ 90)81%
- Confident(70–90)6%
- Low(50–70)2%
- Very low(< 50)11%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Retinal disorders
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)retinitis pigmentosa 99
neurodegenerative disease
Spastic tetraplegia
spastic quadriplegic cerebral palsy
sleep disorder
osteoporosis
bone fracture
glioblastoma
Parkinson disease
Alzheimer disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial
Regulatory subunit which plays a role in the allosteric regulation of the enzyme catalyzing the decarboxylation of isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have considerable basal activity but the full activity of the heterotetramer (containing two subunits of IDH3A, one of IDH3B and one of IDH3G) requires the assembly and cooperative function of both heterodimers
IDH3G · P51553

Mean pLDDT
88.6/ 100
Confident
393 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0